Drug profile · INN
foscarnet sodium
FOSCARNET SODIUM
foscarnet sodium (FOSCARNET SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — foscarnet sodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
foscarnet sodium (FOSCARNET SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Human herpesvirus 1 DNA polymerase inhibitor
Primary target: DNA polymerase catalytic subunit
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is foscarnet sodium?
foscarnet sodium (FOSCARNET SODIUM) is a human herpesvirus 1 dna polymerase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for foscarnet sodium?
FOSCARNET SODIUM is a marketed brand name for foscarnet sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of foscarnet sodium?
foscarnet sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.